After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Monsanto (MON) stock is reacting favorably to the European Commission's import approval of new genetically modified soybeans for food and livestock feed.
Results from the ChemChina bid target come on the heels of disappointing figures from former suitor Monsanto.
Cramer says he's frustrated with Synergy Pharmaceuticals' situation.
The higher the market goes, so, too, will your risks, Cramer says.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.